Significant overexpression of the Merkel cell polyomavirus (MCPyV) large T antigen in Merkel cell carcinoma

Head and Neck

Volumn 35, Issue 2, 2013, Pages 184-189

  Erovic, Boban M ^a   Al Habeeb, Ayman ^a   Harris, Luke ^a   Goldstein, David P ^a   Ghazarian, Danny ^a   Irish, Jonathan C ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

diagnosis; Merkel cell carcinoma; polyomavirus; prediction; targeted anticancer therapy

Indexed keywords

AMINOMETHYLTRANSFERASE;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; METASTASIS; NECK DISSECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCORING SYSTEM; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BIOPSY, NEEDLE; CARCINOMA, MERKEL CELL; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MERKEL CELL POLYOMAVIRUS; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TUMOR VIRUS INFECTIONS;

EID: 84872827401     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.22942     Document Type: Article

References (12)

1. Tai P,. Merkel cell cancer: update on biology and treatment. Curr Opin Oncol 2008; 20: 196-200.
2. Rockville Merkel Cell Carcinoma Group. Merkel cell carcinoma: recent progress and current priorities on etiology, pathogenesis, and clinical management. J Clin Oncol 2009; 27: 4021-4026.
3. Moll R, Löwe A, Laufer J, Franke WW,. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992; 140: 427-447.
4. Paik JY, Hall G, Clarkson A, et al. Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population. Hum Pathol 2011; 42: 1385-1390.
5. Agelli M, Clegg LX, Becker JC, Rollison DE,. The etiology and epidemiology of Merkel cell carcinoma. Curr Probl Cancer 2010; 34: 14-37.
6. Feng H, Shuda M, Chang Y, Moore PS,. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096-1100.
7. Suárez C, Rodrigo JP, Ferlito A, Devaney KO, Rinaldo A,. Merkel cell carcinoma of the head and neck. Oral Oncol 2004; 40: 773-779.
8. Ihloff AS, Petersen C, Hoffmann M, Knecht R, Tribius S,. Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy. Oral Oncol 2010; 46: 705-711.
9. Voog E, Biron P, Martin JP, Blay JY,. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999; 85: 2589-2595.
10. Kudchadkar R, Deconti R,. Systemic treatments for Merkel cell carcinoma. Curr Probl Cancer 2010; 34: 97-107.
11. Brunner M, Thurnher D, Pammer J, et al. Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma. Mod Pathol 2008; 21: 876-884.
12. Samlowski WE, Moon J, Tuthill RJ, et al. A phase II trial of imatinib mesylate in Merkel cell carcinoma (neuroendocrine carcinoma of the skin): a Southwest Oncology Group study (S0331). Am J Clin Oncol 2010; 33: 495-499.